/
/
/

Marksans Pharma Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)333.00
Volume (₹)12.84 L
High (₹)335.45
Upper Circuit398.60
Low (₹)323.45
Lower Circuit265.80
Prev Close332.20
52W High (₹)345.50
Price326.50
52W Low (₹)155.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)15036.00 Cr
Div. Yield (%)0.27
PE Ratio29.10
Debt to Equity0.01
Price to Book2.36
Book Value66.64
EPS (TTM)11.40
Face Value1.00
ROE (%)15.31

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
MARKSANSNSE
LTP
1W Low
1W High
Market cap (₹)
1899.4-20.6 (-1.07%)
1896.80
1984.80
4,56,833Cr
9135-104 (-1.13%)
9087
9467
2,45,426Cr
4838.5-211.5 (-4.19%)
4823
5066
1,87,320Cr
1129.6-61.4 (-5.16%)
1125.10
1187
1,13,217Cr
1380.3-43.2 (-3.03%)
1376
1426.10
1,12,212Cr
1844-94.5 (-4.87%)
1811.70
1949
1,01,155Cr
2110.6-60.9 (-2.80%)
2107.20
2192
97,626Cr
2330.3-52.6 (-2.21%)
2327.30
2419.20
96,859Cr
1156.5-21.5 (-1.83%)
1154.40
1179.90
96,406Cr
1653.8+8.5 (0.52%)
1622.60
1717
93,614Cr
326.5-3.2 (-0.97%)
313.10
341
15,036Cr

Key Highlights of Marksans Pharma Ltd Balance Sheet

Marksans Pharma Ltd balance sheet discloses shareholders' funds of ₹45.32Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹45.32Cr, and the reserves and surplus of the company is ₹1603.66Cr.

The company has its non-current liabilities with total liabilities of ₹2055.64Cr as of 2026-03-31.

The current liabilities are ₹371.86Cr as of 2026-03-31. At the same time, current assets are ₹1370.68Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹267.21Cr and tangible assets of ₹397.96Cr, provided in the Marksans Pharma Ltd financial statements.